The Joint 24th International Conference on Emerging Infectious Diseases in the Pacific Rim of the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) in collaboration with the 2nd International Symposium for Infectious Diseases Research Institutes Cooperation (IDRIC)
.png?width=125&height=125&name=logo1%20(003).png "logo1 (003)")
.png?width=125&height=110&name=NIH_Master_Logo_Vertical_2Color-PNG%20(002).png "NIH_Master_Logo_Vertical_2Color-PNG (002)"){kind=logo}
-1.png?width=250&name=IVI_logo%20(002)-1.png "IVI_logo (002)-1")
Immunology Panel Agenda
Thursday|7 March 2024 | DAY THREE
_______________________________________________________________
8:50-9:00 | Welcome and Introduction | Conrad Mallia, U.S. National Institute of Allergy and Infectious Diseases & Ken Ishii.
9:00-9:20 | Adjuvants and Mucosal Immunity | Jun Kunisawa, National Institutes of Biomedical Innovation, Health, and Nutrition
9:20-9:30 | Discussion
9:30-9:50 | Vaccine Adjuvant Program at the University of California, San Diego | Tomoko Hayashi, UCSD
9:50-10:00 | Discussion
10:00-10:20 | Innate Immune Regulation and Lysosome-targeting Drug Development | Noriko Sorumachi, University of Tokyo, Japan
10:20-10:30 | Discussion
_______________________________________________________________
10:30-10:45 | Break
_______________________________________________________________
10:45-11:05 | Vaccine Adjuvant Development | Harry Kleanthous, SK Bioscience, Cambridge, MA / Seoul, South Korea
11:05-11:15 | Discussion
11:15-11:35 | Vaccine Adjuvant Development | Ken Ishii, Institute of Medical Science, University of Tokyo, Japan
11:35-11:45 | Discussion
_______________________________________________________________
11:45-13:30 | Lunch Break
_______________________________________________________________
13:30-13:50 | Sustainable Next Generation Saponin-based Vaccine Adjuvants | Pi-Hui Liang, ImmunAdd, Taipei City, Taiwan
13:50-14:00 | Discussion
14:00-14:20 | Vaccine Antigen and Antibody Protein Engineering | Satoru Nagatoishi, University of Tokyo, Japan
14:20-14:30 | Discussion
14:30-14:50 | Mucosal Vaccine Adjuvants and IgA | Reiko Shinkura, Laboratory of Immunology and Infection Control, University of Yokyo, Japan
14:50-15:00 | Discussion
15:00-15:20 | Non-Human Primate Models for Vaccines | Yasuhiro Yasutomi, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan
15:20-15:30 | Discussion
15:30 | Wrap-Up and Adjourn Immunology Board Session
Friday| 8 March 2024 | DAY FOUR
_____________________________________________________________
SESSION THREE: Hepatitis Virus-related and Non-viral Liver Cancer - Joint with Immunology Board and Cancer Panel
Moderators: Su-Hyung Park & Toru Kiyono
8:30-8:45 | Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain Diverse RNA Types Produced by HBV Replication and Derived from Integrated HBV DNA | Severin Gudima, USA
8:45-9:00 | Tatsuhiro Shibata, Japan
9:00-9:15 | Regulatory Mechanism of Polycomb Repressive Complex 1 by HCV Infection | Kohji Moriishi, Japan
9:15-9:30 | ILT2 as a Regulator of NK Cells in Patients with HCC | Tatsuya Kanto, Japan
9:30-9:45 | Moleculat Landscape of Liver Cancer and Its Clinical Implications | Xin Wei Wang, USA
9:45-10:10 | Discussion for Talks 20-24
_______________________________________________________________
10:10-10:50 | Coffee Break
_______________________________________________________________
Moderator: Tatsuya Kanto
10:50-11:05 | 4-1BB Co-Stimulation, a Promising Strategy for Treating HCC | Su-Hyung Park, Korea
11:05-11:20 | mRNA-based T-cell Engineering for HBV-related HCC | Antonio Bertoletti, Singapore
11:20-11:35 | Ray Chung, USA
11:35-11:50 | Oxidative Stress Sensor Keap1 Recognixes HBx Protein to Activate the Nrf2/ARE Signaling Pathway, thereby Inhibiting Hepatitis B Virus Replication | Ikuo Shoji, Japan
11:50-12:05 | Epidemiology and Genomic Applications Detect Risk Factors and Discern Treatment Response in Liver Cancer | Anuradha Budhu, USA
12:05-12:30 | Discussion for Talks 25-29
_______________________________________________________________
12:30-13:30 | Lunch Break
12:30-13:30 | Hepatitis Panel Business Meeting
_______________________________________________________________
Moderators: Tatsuhiro Shubata & Xin Wei Wang
13:30-13:40 | Young Investigator 7 | Immune Resilience to Cancer by Repurposing Mycobacterium Tuberculosis-specific CD4 Memory Th1 Cells | Burcu Temizoz
13:40-13:50 | Young Investigator 8 | Single Nanoparticle Mapping and Sorting in Biological Fluids and Breath Samples | Shuntaro Shimizu
13:50-14:00 | Young Investigator 9 | A Novel Mechanism of Driving Intrahepatic Cholangiocarcinoma | Takahiro Kodama, Japan
14:00-14:10 | Young Investigator 10 | Differential T-cell and Monocyte Responses in Hepatocellular Carcinoma Treated with Regorafenib Plus Nivolumab | Hyung-Don Kum, Korea
14:10-14:20 | Young Investigator 11 | Laminin y2 Monomer, a Novel Biomarker for Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection | Kouki Nio, Japan
14:20-14:30- Young Investigator 12 | Role of Hepcidin Upregulation and Proteolytic Cleavage of Ferroportin 1 in Hepatitis C Virus-induced Iron Accumulation | Kazuyoshi Ohta, Japan
14:30-15:00 | Discussion for Young Investigators 7-12
15:00-15:15 | Wrap-up and Plans for a Report | Ray Chung & Tatsuya Kanto
15:15 | Adjourn 37th Hepatitis / Immunology / Cancer Panel Meeting